blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2332575

EP2332575 - Treatment of cancer with novel anti-IL 13 monoclonal antibodies [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.09.2015
Database last updated on 28.03.2026
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): LU		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080 / US
[2011/24]
Inventor(s)01 / Fung, Sek Chung
922 Beacon Square Court, No. 425
Gaithersburg, MD 20878 / US
02 / Moyle, Matthew
15737 NE 134th Street
Redmond, WA 98052 / US
 [2011/24]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2014/46]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Former [2011/24]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date10179775.123.12.2004
[2011/24]
Priority number, dateUS20030532130P23.12.2003         Original published format: US 532130 P
[2011/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2332575
Date:15.06.2011
Language:EN
[2011/24]
Type: B1 Patent specification 
No.:EP2332575
Date:12.11.2014
Language:EN
[2014/46]
Search report(s)(Supplementary) European search report - dispatched on:EP12.04.2011
ClassificationIPC:A61K39/395, A61P35/00, G01N33/53, C07K16/24
[2014/24]
CPC:
C07K16/244 (EP,US); C07K16/00 (KR); A61K39/395 (KR,RU);
A61P1/04 (EP); A61P11/00 (EP); A61P11/02 (EP);
A61P11/06 (EP); A61P17/00 (EP); A61P17/02 (EP);
A61P17/04 (EP); A61P19/10 (EP); A61P27/02 (EP);
A61P29/00 (EP); A61P31/12 (EP); A61P35/00 (EP);
A61P35/04 (EP); A61P37/00 (EP); A61P37/08 (EP);
A61P43/00 (EP); C07K7/06 (RU); C07K7/08 (RU);
A61K2039/505 (EP,US); A61K2039/55522 (US); C07K2317/24 (EP,US);
C07K2317/34 (EP,US); C07K2317/56 (EP,US); C07K2317/565 (EP,US);
C07K2317/567 (EP,US); C07K2317/73 (EP,US); C07K2317/76 (EP,US);
C07K2317/92 (EP,US) (-)
Former IPC [2011/24]A61K39/395, A61P35/00, G01N33/53, // C07K16/24
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/24]
TitleGerman:Behandlung von Krebs mit neuen monoklonalen anti-IL-13-Antikörpern[2011/24]
English:Treatment of cancer with novel anti-IL 13 monoclonal antibodies[2011/24]
French:Traitement du cancer au moyen de nouveaux anticorps monoclonaux anti-IL 13[2011/24]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure15.12.2011Amendment by applicant (claims and/or description)
15.12.2011Examination requested  [2012/04]
13.02.2012Despatch of a communication from the examining division (Time limit: M06)
01.10.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
10.12.2012Reply to a communication from the examining division
09.01.2013Despatch of a communication from the examining division (Time limit: M06)
18.07.2013Reply to a communication from the examining division
20.05.2014Communication of intention to grant the patent
26.09.2014Fee for grant paid
26.09.2014Fee for publishing/printing paid
26.09.2014Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP04815598.0  / EP1711528
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040815598) is  19.11.2007
Opposition(s)13.08.2015No opposition filed within time limit [2015/43]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
10.12.2012Request for further processing filed
10.12.2012Full payment received (date of receipt of payment)
Request granted
02.01.2013Decision despatched
Fees paidRenewal fee
13.01.2011Renewal fee patent year 03
13.01.2011Renewal fee patent year 04
13.01.2011Renewal fee patent year 05
13.01.2011Renewal fee patent year 06
15.12.2010Renewal fee patent year 07
12.12.2011Renewal fee patent year 08
11.12.2012Renewal fee patent year 09
06.12.2013Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.12.2004
AT12.11.2014
BG12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
FI12.11.2014
LT12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
IE23.12.2014
LU23.12.2014
BE31.12.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
[2016/33]
Former [2016/32]HU23.12.2004
AT12.11.2014
BG12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
FI12.11.2014
LT12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
IE23.12.2014
BE31.12.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2016/25]AT12.11.2014
BG12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
FI12.11.2014
LT12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
IE23.12.2014
BE31.12.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2016/12]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
FI12.11.2014
LT12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
IE23.12.2014
BE31.12.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/46]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
FI12.11.2014
LT12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
IE23.12.2014
BE31.12.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/39]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
FI12.11.2014
LT12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
BE31.12.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/37]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
FI12.11.2014
LT12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
BE31.12.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/36]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
FI12.11.2014
LT12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
BE31.12.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/35]AT12.11.2014
CY12.11.2014
DK12.11.2014
EE12.11.2014
FI12.11.2014
LT12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
BE31.12.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/30]AT12.11.2014
CY12.11.2014
FI12.11.2014
LT12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
BE31.12.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/26]AT12.11.2014
CY12.11.2014
FI12.11.2014
LT12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/25]AT12.11.2014
FI12.11.2014
LT12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/24]FI12.11.2014
LT12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/23]FI12.11.2014
LT12.11.2014
NL12.11.2014
IS12.03.2015
PT12.03.2015
Former [2015/22]LT12.11.2014
PT12.03.2015
Former [2015/20]LT12.11.2014
Documents cited:Search[I] US2003049257  (MAK TAK W et al.)
 [A] WO02055100  (INST GENETICS LLC et al.)
 [I]   SKINNIDER BRIAN F ET AL: "The role of interleukin 13 in classical Hodgkin lymphoma.", LEUKEMIA & LYMPHOMA JUN 2002, vol. 43, no. 6, June 2002 (2002-06-01), pages 1203 - 1210, XP008078949, ISSN: 1042-8194

DOI:   http://dx.doi.org/10.1080/10428190290026259
 [I]   SKINNIDER BRIAN F ET AL: "Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.", BLOOD 15 JAN 2002, vol. 99, no. 2, 15 January 2002 (2002-01-15), pages 618 - 626, XP008079082, ISSN: 0006-4971

DOI:   http://dx.doi.org/10.1182/blood.V99.2.618
 [I]   KAPP U ET AL: "INTERLEUKIN 13 IS SECRETED BY AND STIMULATES THE GROWTH OF HODGKIN AND REED-STERNBERG CELLS", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, vol. 189, no. 12, 1999, pages 1939 - 1945, XP000914767, ISSN: 0022-1007

DOI:   http://dx.doi.org/10.1084/jem.189.12.1939
 [AP]   WYNN THOMAS A: "IL-13 effector functions.", ANNUAL REVIEW OF IMMUNOLOGY. VOLUME 21 ANNUAL REVIEWS, 4139 EL CAMINO WAY, P. O. BOX 10139, PALO ALTO, CA, 94303-0139, USA SERIES : ANNUAL REVIEW OF IMMUNOLOGY (ISSN 0732-0582 (ISSN PRINT)), 2003, pages 425 - 456, XP008079048

DOI:   http://dx.doi.org/10.1146/annurev.immunol.21.120601.141142
 [A]   TRIEU YOUNG ET AL: "Inhibition of Hodgkin Lymphoma Cell Line Growth Using an Adenovirus Expressing the Soluble IL-13 Decoy Receptor (sIL-13Ralpha2).", BLOOD, vol. 100, no. 11, 16 November 2002 (2002-11-16), & 44TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY; PHILADELPHIA, PA, USA; DECEMBER 06-10, 2002, XP008078909, ISSN: 0006-4971
 [A]   OSHIMA Y ET AL: "Characterization of a powerful high affinity antagonist that inhibits biological activities of human interleukin-13", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 276, no. 18, 4 May 2001 (2001-05-04), pages 15185 - 15191, XP002239705, ISSN: 0021-9258

DOI:   http://dx.doi.org/10.1074/jbc.M010159200
 [A]   MCKENZIE A N ET AL: "Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 15 APR 1993, vol. 90, no. 8, 15 April 1993 (1993-04-15), pages 3735 - 3739, XP002948382, ISSN: 0027-8424

DOI:   http://dx.doi.org/10.1073/pnas.90.8.3735
by applicantUS5939598
 US5652123
 US4376110
 US4816567
 US5807715
 US4816397
 US5585089
 EP0239400
 WO9109967
 US5225539
 US5530101
 EP0592106
 EP0519596
 US5565332
 US4444887
 US4716111
 WO9846645
 WO9850433
 WO9824893
 WO9816654
 WO9634096
 WO9633735
 WO9110741
 WO9201047
 EP0598877
 US5413923
 US5625126
 US5633425
 US5569825
 US5661016
 US5545806
 US5814318
 US5885793
 US5916771
 WO9308829
 US4676980
 WO9425591
 US2003130496
 WO9317715
 WO9208802
 WO9100360
 WO9205793
 US4474893
 US4714681
 US4925648
 US5573920
 US5601819
 US5698435
 WO8605807
 WO8901036
 US5122464
 US4946778
 WO9321232
 EP0439095
 US5474981
 US4741900
 US5441050
 US6514496
 WO9208495
 WO9114438
 WO8912624
 US5314995
 EP0396387
 WO9733899
 WO9734911
 WO9923105
   HERSHEY, GKK, J ALLERGY CFIN LMMUNOL., vol. 111, 2003, pages 677 - 90
   WYNN, TA, ANNU REV IMMUNOL., vol. 21, 2003, pages 425 - 56
   WYNN TA., NAT REV IMMUNOL., vol. 4, 2004, pages 583 - 94
   HELLER F ET AL., IMMUNITY, vol. 17, 2002, pages 629 - 38
   KAPP U ET AL., J EXP MED., vol. 189, 1999, pages 1939 - 4
   TRIEU Y ET AL., CANCER RES., vol. 64, 2004, pages 3271 - 5
   TERABE M ET AL., CANCER IMMUNOL IMMUNOTHER., vol. 53, 2004, pages 79 - 85
   TERABE M ET AL., NAT IMMUNOL., vol. 1, 2000, pages 515 - 20
   DEBINSKI W ET AL., J BIOL CHEM., vol. 270, 1995, pages 16775 - 80
   PURI RK ET AL., BLOOD, vol. 87, 1996, pages 4333 - 9
   MAINI A ET AL., J UROL., vol. 158, 1997, pages 948 - 53
   DEBINSKI W ET AL., CLIN CANCER RES., vol. 1, 1995, pages 1253 - 8
   KOMMANN M ET AL., ANTICANCER RES., vol. 19, 1999, pages 125 - 31
   HUSAIN SR ET AL., BLOOD, vol. 95, 2000, pages 3506 - 13
   KAWAKAMI K ET AL., CANCER RES., vol. 61, 2001, pages 6194 - 6200
   WAHL ET AL., J. NUD. MED., vol. 24, 1983, pages 316 - 325
   CLYNES ET AL., PNAS, vol. 95, 1998, pages 652 - 656
   THOMPSON ET AL., J. BIOL. CHEM., vol. 274, 1999, pages 2994
   HARLOW ET AL.: "Antibodies: a Laboratory Manual, 2nd ed.", 1988, COLD SPRING HARBOR LABORATORY PRESS
   KOHLER; MILSTEIN, NATURE, vol. 256, 1975, pages 495
   HARLOW ET AL.: "Antibodies: A Laboratory Manual, 2.sup.nd ed.", 1988, COLD SPRING HARBOR LABORATORY PRESS
   HAMMERLING ET AL.: "Monoclonal Antibodies and T-Cell Hybridomas", 1981, ELSEVIER
   KOSBOR ET AL., IMMUNOLOGY TODAY, vol. 4, 1983, pages 72
   COLE ET AL., PROC. NATI. ACAD. SCI. USA, vol. 80, 1983, pages 2026 - 2030
   COLE ET AL.: "Monoclonal Antibodies And Cancer Therapy", 1985, ALAN R. LISS, INC., pages: 77 - 96
   GODING: "Monoclonal Antibodies: Principles and Practice", 1986, ACADEMIC PRESS, pages: 59 - 103
   KOZBOR, J. IMMUNOL., vol. 133, 1984, pages 3001
   BRODEUR ET AL.: "Monoclonal Antibody Production Techniques and Applications", 1987, MARCEL DEKKER, INC., pages: 51 - 63
   MUNSON ET AL., ANAL BIOCHEM., vol. 107, 1980, pages 220
   MORRISON, SCIENCE, vol. 229, 1985, pages 1202
   OI, BIOTECHNIQUES, vol. 4, 1986, pages 214
   GILLIES ET AL., J. IMMUNOL. METHODS, vol. 125, 1989, pages 191 - 202
   RIECHMANN ET AL., NATURE, vol. 332, 1988, pages 323
   PADLAN, MOLECULAR IMMUNOLOGY, vol. 28, no. 4/5, 1991, pages 489 - 498
   STUDNICKA ET AL., PROTEIN ENGINEERING, vol. 7, no. 6, 1994, pages 805 - 814
   ROGUSKA. ET AL., PNAS, vol. 91, 1994, pages 969 - 973
   JONES, NATURE, vol. 321, 1986, pages 522 - 525
   REICHMANN ET AL., NATURE, vol. 332, 1988, pages 323 - 327
   VERHOEYEN ET AL., SCIENCE, vol. 239, 1988, pages 1534,1536
   COLE ET AL.: "Monoclonal Antibodies and Cancer Therapy", 1985, ALAN R. RISS
   BOERNER ET AL., J. IMMUNOL., vol. 147, no. 1, 1991, pages 86 - 95
   LONBERG; HUSZAR, LNT, REV. LMMUNOL., vol. 13, 1995, pages 65 - 93
   JESPERS ET AL., BIOLTECHNOLOGY, vol. 12, 1988, pages 899 - 903
   GREENSPAN; BONA, FASEB J., vol. 7, no. 5, 1989, pages 437 - 444
   NISSINOFF, J. LMMUNOL., vol. 147, no. 8, 1991, pages 2429 - 2438
   MILSTEIN; CUELLO, NATURE, vol. 305, 1983, pages 537 - 539
   TRAUNECKER ET AL., EMBO J., vol. 1, no. 0, 1991, pages 3655 - 3659
   SURESH ET AL., METH. IN ENZYM., vol. 121, 1986, pages 210
   TUTT ET AL., J. IMMUNOL., vol. 147, 1991, pages 60 - 69
   KOSTEINY ET AL., J. IMMUNOL., vol. 148, 1992, pages 1547 - 1553
   STUDIER, F.W., J. MOL. BIOL., vol. 219, 1991, pages 37
   SCHOEPFER, R., GENE, vol. 124, 1993, pages 83
   ROSENBERG ET AL., GENE, vol. 56, 1987, pages 125 - 135
   CHANG ET AL., NATURE, vol. 275, 1978, pages 615
   GOEDDEL ET AL., NATURE, vol. 281, 1979, pages 544
   GOEDDEL ET AL., NUCL. ACIDS RES., vol. 8, 1980, pages 4057
   SAMBROOK ET AL.: "Molecular Cloning, A Laboratory Manual, 2d Ed.,", 1990, COLD SPRING HARBOR LABORATORY
   HITZEMAN ET AL., J. BIOL. CHEM., vol. 255, 1980, pages 2073
   HOLLAND ET AL., BIOCHEM., vol. 17, 1978, pages 4900
   FLEER ET AL., GENE, vol. 107, 1991, pages 285 - 195
   HINNEN, PROC. NATL. ACAD. SCI., vol. 75, 1978, pages 1929
   KUTMEIER ET AL., BIOTECHNIQUES, vol. 17, 1994, pages 242
   "Current Protocols in Molecular Biology", 1998, JOHN WILEY & SONS
   CHOTHIA ET AL., J. MOL. BIOL., vol. 278, 1998, pages 457 - 479
   MORRISON ET AL., PROC. NATI. ACAD. SCI., vol. 81, 1984, pages 851 - 855
   NEUBERGER ET AL., NATURE, vol. 312, 1984, pages 604 - 608
   TAKEDA ET AL., NATURE, vol. 314, 1985, pages 452 - 454
   BIRD, SCIENCE, vol. 242, 1988, pages 423 - 42
   HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883
   WARD ET AL., NATURE, vol. 334, 1989, pages 544 - 54
   SKERRA ET AL., SCIENCE, vol. 242, 1988, pages 1038 - 1041
   FOECKING ET AL., GENE, vol. 45, 1986, pages 101
   COCKETT, BIO/TECHNOLOGY, vol. 8, 1990, pages 2
   WIGLER ET AL., CELL, vol. 11, 1977, pages 223
   SZYBALSKA; SZYBALSKI, PROC. NATL. ACAD. SCI. USA, vol. 48, 1992, pages 202
   LOWY ET AL., CELL, vol. 22, 1980, pages 817
   WIGLER, PROC. NATL. ACAD. SCI._ USA, vol. 77, 1980, pages 357
   O'HARE ET AL., PROC, NAT). ACAD. SCI. USA, vol. 78, 1981, pages 1527
   MULLIGAN; BERG, PROC. NATL. ACAD. SCI, USA, vol. 78, 1981, pages 2072
   WU; WU, BIOTHERAPY, vol. 3, 1991, pages 87 - 95
   SANTERRE ET AL., GENE, vol. 30, 1984, pages 147
   "Current Protocols in Molecular Biology", 1993, JOHN WILEY & SONS
   KRIEGIER: "Gene Transfer and Expression, A Laboratory Manual", 1990, STOCKTON PRESS
   "Current Protocols in Human Genetics", 1994, JOHN WILEY & SONS
   COLBERRE-GARAPIN, J. MOL, BIOL., vol. 150, 1981, pages 1
   "DNA Cloning", vol. 3, 1987, ACADEMIC PRESS
   CROUSE ET AL., MOL. CELL. BIOL., vol. 3, 1983, pages 257
   PROUDFOOT, NATURE, vol. 322, 1986, pages 52
   KOHLER, PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 2197
   NARAMURA ET AL., IMMUNOL. LETT., vol. 39, 1994, pages 91 - 99
   GILLIES ET AL., PROC. NATL. ACAD. SCI., vol. 89, 1992, pages 1428 - 1432
   FELL ET AL., J. IMMUNOL., vol. 146, 1991, pages 2446 - 2452
   GENTZ ET AL., PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 821 - 824
   WILSON ET AL., CELL, vol. 37, 1984, pages 767
   HARLOW ET AL.: "Antibodies: A Laboratory Manual,2nd ed.", 1988, COLD SPRING HARBOR LABORATORY PRESS
   JALKANEN ET AL., J. CELL. BIOL., vol. 101, 1985, pages 976 - 985
   JALKANEN ET AL., J. CELL. BIOL., vol. 105, 1987, pages 3087 - 3096
   S. W. BURCHIEL ET AL.: "Tumor imaging: The Radiochemical Detection of Cancer", 1982, MASSON PUBLISHING INC., article "Immunopharmacokineties of Radiolabeled Antibodies and Their Fragments"
   LANGER, SCIENCE, vol. 249, 1990, pages 1527 - 1533
   TREAT ET AL.: "Liposomes in the Therapy of Infectious Disease and Cancer", 1989, LISS, pages: 353 - 365
   SEFTON, CRC CRIT. REF. BIOMED. ENG., vol. 14, 1987, pages 201
   BUCHWALD ET AL., SURGERY, vol. 88, 1980, pages 507
   SAUDEK ET AL., N. ENGL. J. MED., vol. 321, 1989, pages 574
   "Medical Applications of Controlled Release", 1974, CRC PRES.
   "Controlled Drug Bioavailability, Drug Product Design and Performance", 1984, WILEY
   RANGER; PEPPAS, J., MACROMOL. SCI. REV. MACROMOL CHEM., vol. 23, 1983, pages 61
   LEVY ET AL., SCIENCE, vol. 228, 1985, pages 190
   DURING ET AL., ANN, NEURO!, vol. 25, 1989, pages 351
   HOWARD ET AL., J. NEUROSURG., vol. 71, 1989, pages 105
   ARNON ET AL.: "Monoclonal Antibodies And Cancer Therapy", 1985, ALAN R. LISS, INC., article "Monoclonal Antibodies For Immunotargeting Of Drugs In Cancer Therapy", pages: 243 - 56
   HELISTROM ET AL.: "Controlled Drug Delivery(2nd Ed.)", 1987, MARCEL DEKKER, INC., article "Antibodies For Drug Delivery", pages: 623 - 53
   THORPE ET AL.: "Monoclonal Antibodies '84: Biological And Clinical Applications", 1985, article "Antibody Carriers Of Cytotoxic Agents In Cancer Therapy: A Review", pages: 475 - 506
   "Monoclonal Antibodies For Cancer Detection And Therapy", 1985, ACADEMIC PRESS, article "Analysis, Results, And Future Prospective Of The Therapeutic Use Of Radiolabeled Antibody In Cancer Therapy", pages: 303 - 16
   THORPE ET AL.: "The Preparation And Cytotoxic Properties Of Antibody-Toxin Conjugates", LMMUNOL. REV., vol. 62, 1982, pages 119 - 58
   TAKAHASHI ET AL., INT. IMMUNOL., vol. 6, 1994, pages 1567 - 1574
   THOMPSON ET AL., J. BIOL, CHEM., vol. 274, 1999, pages 29944
   KAPP U, J. EXP. MED., vol. 189, 1999, pages 1939
   DE WAAL MALEFYT ET AL., J. IMMUNOL., vol. 151, 1993, pages 6370
   CHOMARAT ET AL., LNT. REV. LMMUNOI., vol. 17, 1998, pages 1
   MURATA T ET AL., INT. IMMUNOL., vol. 10, 1998, pages 1103 - 1110
   O'BRIEN S.; JONES T.: "Antibody Engineering", 2001, SPRINGER LAB MANUAL, article "Humanizing antibodies by CDR grafting"
   GLASER S. ET AL.: "Antibody Engineering", 1995, OXFORD UNIVERSITY PRESS
   NEAR RI, BIOTECHNIQUES, vol. 12, 1992, pages 88
   L. M. WEINER ET AL., CANCER RES., vol. 48, 1988, pages 2568 - 2573
   P. HERSEY ET AL., CANCER RES., vol. 46, 1988, pages 6083 - 6090
   C. J. HANSIK ET AL., PROC. NATL, ACAD. SCI., vol. 83, 1986, pages 7893 - 97
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.